title: Risk of death from recurrent ischemic events after intravenous streptokinase in acute myocardial infarction: results from the Intravenous Streptokinase in Myocardial Infarction (ISAM) Study.
authors.forename: R
authors.initials: R
authors.lastname: Schröder
authors.forename: K L
authors.initials: KL
authors.lastname: Neuhaus
authors.forename: T
authors.initials: T
authors.lastname: Linderer
authors.forename: A
authors.initials: A
authors.lastname: Leizorovicz
authors.forename: K
authors.initials: K
authors.lastname: Wegscheider
authors.forename: U
authors.initials: U
authors.lastname: Tebbe
mesh_terms: D002986:Clinical Trials as Topic; D004311:Double-Blind Method; D006801:Humans; D007275:Injections, Intravenous; D009203:Myocardial Infarction / Q000188:drug therapy* / Q000401:mortality; D011446:Prospective Studies; D012008:Recurrence; D012306:Risk; D013300:Streptokinase / Q000008:administration & dosage / Q000627:therapeutic use*
chemical_list: D013300:Streptokinase